Work

Phase 1 trial of trametinib alone and in combination with dabrafenib in children and adolescents with relapsed solid tumors or neurofibromatosis type 1 (NF1) progressive plexiform neurofibromas (PN).

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.10537

Authors: Birgit Geoerger, Christopher L. Moertel, James Whitlock, Geoffrey Brian McCowage, Mark W. Kieran, Alberto Broniscer, Darren R Hargrave, Pooja Hingorani, Lindsay Baker Kilburn, Sabine Mueller, Lillian Tseng, Noelia Nebot, Kohinoor Dasgupta, Mark W. Russo, Elizabeth Fox

Institutions: Institut Gustave Roussy, University of Minnesota, University of Toronto, Hospital for Sick Children, Children's Hospital at Westmead, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, St. Jude Children's Research Hospital, Great Ormond Street Hospital, Phoenix Children's Hospital, Children's National, University of California, San Francisco, Novartis (India), Children's Hospital of Philadelphia

Language: English

Topic: Neurofibromatosis and Schwannoma Cases

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891214711

Cites:

Cited by: 30

Related to: 10